GEMINI THERAPEUTICS INC (GMTX) Stock News

USA - NASDAQ:GMTX - US36870G1058 - Common Stock

1.35 USD

0 (0%)

Last: 12/29/2022, 8:00:02 PM

1.32 USD

-0.03 (-2.22%)

After Hours: 12/29/2022, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

GMTX Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation

3 years ago - By: Benzinga - Mentions: NNOX ELYS SPI LJAQ ...

Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket

3 years ago - By: Disc Medicine

Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria

3 years ago - By: InvestorPlace - Mentions: GHRS JANX OFLX RDVT ...

7 Short-Squeeze Stocks for Bold Contrarians to Consider

3 years ago - By: Benzinga

Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company

3 years ago - By: Disc Medicine

Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)

3 years ago - By: Kahn Swick & Foti, LLC

GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX

3 years ago - By: Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Gemini Therapeutics, Inc.

3 years ago - By: Halper Sadeh LLP

GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders

3 years ago - By: Gemini Therapeutics, Inc.

Gemini Therapeutics and Disc Medicine Announce Merger Agreement